Clinical Trial Update: Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing two tacrolimus-based immunosuppressant regimens with thymoglobulin induction in deceased-donor expanded-criteria kidney trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• End-stage Renal Disease

Drugs mentioned

• Tacrolimus (Prograf) (tacrolimus)
• Tacrolimus (generic) (Tacrolimus)
• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Helio Tedesco Silva Junior | Conditions: Kidney Transplantation, Cytomegalovirus | Phase 4 | Status: COMPLETED